UWM HOLDINGS CORPORATION

Mr. Del Gaizo served as co-lead counsel for shareholders of Gores IV, a special purpose acquisition corporation, who were entitled to redeem their shares of Gores in connection with Gores’ business combination with SFS Holding Corp., United Wholesale Mortgage, LLC, and UWM Holdings, LLC (collectively, “Legacy UWM”), creating UWM Holdings Corporation. Shareholders sued for breach of fiduciary duty noting the Proxy’s patently unattainable financial projections, especially because Gores’ board should have known that mortgage originations were significantly slowing. After extensive discovery, Robbins LLP secured $17.5 million for the class. In re Gores Holdings IV, Inc. Stockholder Litigation, C.A. No. 2023-0284-LWW (Del Ch. July 15, 2025).

QUANTUMSCAPE CORPORATION

Mr. Del Gaizo served as co-lead counsel for the class of Kensington Capital Acquisition Corp. stockholders who were entitled to redeem their shares of stock in connection with the Company’s merger with Legacy QuantumScape Corporation. Shareholders sued for breach of fiduciary duty alleging the Proxy included misleading claims about the due diligence done by the Kensington Board, the value of Legacy QuantumScape, and the capabilities of Legacy QuantumScape’s technology. After more than 3 years of litigation, Mr. Del Gaizo was able to secure $8.75 million for the class. In re Kensington-QuantumScape De-SPAC Litigation, C.A. No. 2022-0721-JTL (Del. Ch. July 11, 2025)

AVEPOINT, INC.

Mr. Del Gaizo served as co-lead counsel to secure $14.4 million for stockholders who were misled in connection with the business combination of Apex Technology Acquisition Corporation, a special purpose acquisition company, and AvePoint, Inc. Shareholders sued for breach of fiduciary duty alleging that the Proxy contained multiple materially false and misleading representations about AvePoint’s value and prospects and the extent of the director and officers’ misaligned pecuniary interests. Drulias v. Apex Technology Sponsor LLC, et al., C.A. No. 2024-0094-LWW (Del Ch. July 10, 2025).

VIEW, INC.

Mr. Del Gaizo served as co-lead counsel for the class of shareholders who brought claims arising from the business combination between special purpose acquisition company CF Finance Acquisition Corp. II and Legacy View, Inc., which CF II shareholders voted to approve on March 5, 2021. After reviewing corporate documents and records, plaintiffs filed a complaint against View asserting claims for breach of fiduciary duty resulting from defendants’ alleged impairment of CF II stockholders’ redemption rights in connection with the merger. View filed for bankruptcy relief under chapter 11 of the Bankruptcy Code on April 2, 2024, and sought to release defendants and plaintiffs from future claims. Notwithstanding, the parties to the bankruptcy action agreed that certain causes of action of this matter would be carved out of the Chapter 11 Plan. Through mediation, the parties agreed to settle for $12 million. Siseles, et al. v. Lutnick, et al., C.A. No. 2023-1152-JTL (Del. Ch. Dec. 6, 2024).

SEMA4 HOLDINGS CORP.

Mr. Del Gaizo served as co-lead counsel for the class of CM Life Sciences, Inc. shareholders who were entitled to redeem their shares of  stock in connection with the Company’s merger with a formerly privately held company, Mount Sinai Genomics, Inc. d/b/a/ Sema4 Holdings Corp.  Shareholders sued for breach of fiduciary duty resulting from defendants’ impairment of CM Life Sciences, Inc. shareholders’ Redemption Right in connection with its merger with Legacy Sema4. Post-merger, GeneDx reported less revenue than projected in the Proxy Statement issued in support of the merger, lowered revenue projections, and announced its exit from one of its core businesses. As a result, GeneDx’s share price fell below $0.50 per share.  After extensive and contested discovery, the parties reached an agreement that resulted in a recovery to the class of $21 million. In Re GeneDx de-SPAC Litigation, C.A. No. 2023-0140-PAF (Del. Ch. Dec. 2, 2024).

TOLL BROTHERS, INC.

Mr. Del Gaizo led Robbins LLP’s discovery efforts in litigation on behalf of luxury homebuilder Toll Brothers, Inc. in which plaintiffs alleged that certain company officers and directors, including the co-founders, traded on inside information and grossly misled investors about company projections during a housing market downturn. After four years of contentious litigation, the firm secured a settlement that resulted in a $16.25 million settlement, one of the largest Brophy (Brophy v. Cities Serv. Co., 70 A.2d 5 (Del. Ch. 1949)) recoveries ever. Pfeiffer v. Toll, No. 4140-VCL, slip op. (Del. Ch. Mar. 15, 2013).

Mr. Del Gaizo played a leading role in a shareholder derivative action involving Vitacost.com that helped save the $158 million market cap company from bankruptcy and preserved the equity interests of its shareholders. With Mr. Del Gaizo’s help, Robbins LLP achieved a settlement that enabled the company to bring its financial statement and SEC filings current; allowed Vitacost to hold a long overdue shareholder meeting to address fundamental defects in the corporation’s formation, board composition, and past stock issuances; and helped the company to persuade NASDAQ to lift its trading moratorium and provide the company and its shareholders access to the capital markets. Kloss v. Kerker, No. 50-2010-CA-018594-XXXX-MB (Fla. Cir. Ct.-Palm Beach Cnty. May 27, 2011).

Mr. Del Gaizo was a member of the litigation team that led the charge on behalf of the plaintiff who challenged Cardinal Health’s proposed stock-for-stock acquisition of Syncor International Corp. During the course of the litigation, which forced Cardinal Health to reduce the previously negotiated acquisition price for Syncor – saving the company millions of dollars – plaintiffs’ attorneys discovered that Cardinal Health insiders had engaged in a massive revenue inflation scheme to fraudulently overstate the company’s financial performance. After protracted litigation, the firm secured a payment of $70 million to the company, one of the largest shareholder derivative monetary recoveries in history, and required Cardinal Health’s board of directors to implement significant corporate governance and internal account controls to improve oversight and prevent recurrence of the alleged accounting manipulations. In re Cardinal Health Derivative Litigation, No. 02-CVG-11-639 (Ohio Ct. C.P.-Del. County Dec. 17, 2007).